NexgenRx Inc. (TSXV:NXG)
0.3600
+0.0200 (5.88%)
Jun 30, 2025, 4:00 PM EDT
NexgenRx Revenue
NexgenRx had revenue of 4.55M CAD in the quarter ending March 31, 2025, with 8.14% growth. This brings the company's revenue in the last twelve months to 16.82M, up 15.22% year-over-year. In the year 2024, NexgenRx had annual revenue of 16.48M with 18.99% growth.
Revenue (ttm)
16.82M
Revenue Growth
+15.22%
P/S Ratio
1.52
Revenue / Employee
840.89K
Employees
20
Market Cap
25.60M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.48M | 2.63M | 18.99% |
Dec 31, 2023 | 13.85M | 1.07M | 8.33% |
Dec 31, 2022 | 12.78M | 939.94K | 7.94% |
Dec 31, 2021 | 11.84M | 1.27M | 12.01% |
Dec 31, 2020 | 10.57M | 1.03M | 10.82% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sienna Senior Living | 896.45M |
Green Thumb Industries | 1.64B |
dentalcorp Holdings | 1.58B |
Extendicare | 1.47B |
WELL Health Technologies | 990.34M |
Cronos Group | 179.08M |
Trulieve Cannabis | 1.71B |
Curaleaf Holdings | 1.89B |
NexgenRx News
- 6 weeks ago - NexgenRx Announces First Quarter Results With Solid Revenue Growth and Positive EBITDA - Accesswire
- 2 months ago - NexgenRx (NXG) Maintains Quarterly Dividend - GuruFocus
- 2 months ago - NexgenRx declares CAD 0.005 dividend - Seeking Alpha
- 2 months ago - NexgenRx Announces Declaration of Divdend - Accesswire
- 3 months ago - Nexgenrx reports FY results - Seeking Alpha
- 3 months ago - NexgenRx Announces 2024 Year End Results with Continued Strong Revenue Growth and Increasing Positive EBITDA - Accesswire
- 7 months ago - NexgenRx Announces Third Quarter Results and Declaration of Divdend - Accesswire
- 9 months ago - NexgenRX Announces Director Re-Appointment - Accesswire